Evenity approved to treat osteoporosis in postmenopausal women

The U.S. Food and Drug Administration approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies. More than 10 million people … Read more

Exercise may reduce breast cancer risk

Exercise, even mild physical activity, may reduce breast cancer risk – A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity ? either mild or intense and before or after menopause ? may reduce breast cancer risk, but substantial weight gain may negate these benefits. The findings indicate that women can reduce their breast cancer risk by exercising and maintaining their weight.

Increasing height and body mass index linked to ovarian cancer risk

Increasing height and body mass index are risk factors for ovarian cancer – Increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer in women, revealed by researchers.

Pfizer new drug could provide a new treatment option for postmenopausal women

Pfizer new drug BZA/CE could provide a new treatment option for symptomatic postmenopausal women with a uterus – Pfizer Inc. will announce new one-year results from the Selective estrogens, Menopause, And Response to Therapy [SMART]-5 Phase 3 study of the safety and efficacy of the investigational tissue selective estrogen complex (TSEC) bazedoxifene/conjugated estrogens (BZA/CE) at the 22nd annual meeting of the North American Menopause Society (NAMS), September_21-24 in Washington, D.C.

Soy isoflavone tablets not reducing bone loss or menopausal symptoms

Soy tablets not associated with reduction in bone loss or menopausal symptoms in women – Soy isoflavone tablets do not appear to reduce bone loss or menopausal symptoms in women within the first five years of menopause, revealed by researchers recently in a study reported in Archives of Internal Medicine.

Therapy reduces early menopause for women with breast cancer

Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer – Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.

Blood pressure changes are age related but important for health

Blood pressure changes are age-related – The main causes of increases in blood pressure over a lifetime are modifiable and could be targeted to help prevent cardiovascular disease: although high blood pressure sometimes has no obvious symptoms, this condition, which affects about a third of the adult UK and US populations, can lead to life-threatening heart attacks and stroke, so reducing blood pressure is very important for health.

Facial wrinkles may predict bone density in early menopause

Severity of facial wrinkles may predict bone density in early menopause – In postmenopausal women the appearance of the skin may offer a glimpse of the skeletal well-being, a relationship not previously described, said Lubna Pal, MD, a reproductive endocrinologist and associate professor at Yale School of Medicine, New Haven, Conn. The worse a woman’s skin wrinkles are during the first few years of menopause, the lower her bone density is.

Coffee may reduce breast cancer risk

Coffee reduces breast cancer risk – Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa.

Do NOT follow this link or you will be banned from the site!